Literature DB >> 29421563

Lipophilic indocarbocyanine conjugates for efficient incorporation of enzymes, antibodies and small molecules into biological membranes.

Weston J Smith1, Huy Tran2, James I Griffin3, Jessica Jones3, Vivian P Vu3, Lizanne Nilewski4, Nathan Gianneschi4, Dmitri Simberg5.   

Abstract

Decoration of cell membranes with biomolecules, targeting ligands and imaging agents is an emerging strategy to improve functionality of cell-based therapies. Compared to covalent chemistry or genetic expression on the cell surface, lipid painting (i.e., incorporation of lipid-conjugated molecules into the cell bilayer) is a fast, non-damaging and less expensive approach. Previous studies demonstrated excellent incorporation and retention of distearyl indocarbocyanine dye DiI in membranes of cells in vitro and in vivo. In order to exploit the membrane stability of DiI, we synthesized an amino-DiI derivative, to which we subsequently conjugated an antibody (cetuximab), an enzyme (superoxide dismutase), and a small molecule (DyLight 800). Red blood cells have long been used as drug delivery vehicles so they were utilized as a model to study the incorporation of DiI conjugates in the plasma membrane. All the DiI constructs demonstrated fast and efficient ex vivo incorporation in the membrane of mouse RBCs, resulting in millions of exogenous molecules per RBC. Following an intravenous injection into mice, the molecules were detected on circulating RBCs for several days. DiI anchored molecules showed longer residence time in blood and significantly higher area under the curve (AUC) compared to free non-conjugated molecules. Thus, cetuximab, SOD and DyLight painted on RBC showed 5.5-fold, 6.5-fold and 78-fold increase in the AUC, respectively, compared to the non-modified molecules. Lipophilic indocarbocyanine anchors are a promising technology for incorporation of biomolecules and small molecules into biological membranes for in vivo applications.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antibody; DiI; Erythrocyte; Membrane; Near infrared fluorescence; Painting; SOD

Mesh:

Substances:

Year:  2018        PMID: 29421563      PMCID: PMC6179438          DOI: 10.1016/j.biomaterials.2018.01.029

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  46 in total

Review 1.  Long-circulating and target-specific nanoparticles: theory to practice.

Authors:  S M Moghimi; A C Hunter; J C Murray
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

2.  Blood clearance and activity of erythrocyte-coupled fibrinolytics.

Authors:  Kumkum Ganguly; Tatiana Krasik; Sandra Medinilla; Khalil Bdeir; Douglas B Cines; Vladimir R Muzykantov; Juan Carlos Murciano
Journal:  J Pharmacol Exp Ther       Date:  2004-11-03       Impact factor: 4.030

Review 3.  Half-Life Extension of Biopharmaceuticals using Chemical Methods: Alternatives to PEGylation.

Authors:  Søren B van Witteloostuijn; Søren L Pedersen; Knud J Jensen
Journal:  ChemMedChem       Date:  2016-10-24       Impact factor: 3.466

4.  Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis.

Authors:  Sergei Zaitsev; Kristina Danielyan; Juan-Carlos Murciano; Kumkum Ganguly; Tatiana Krasik; Ronald P Taylor; Steven Pincus; Steven Jones; Douglas B Cines; Vladimir R Muzykantov
Journal:  Blood       Date:  2006-05-30       Impact factor: 22.113

5.  Directed targeting of immunoerythrocytes provides local protection of endothelial cells from damage by hydrogen peroxide.

Authors:  V R Muzykantov; D V Sakharov; S P Domogatsky; N V Goncharov; S M Danilov
Journal:  Am J Pathol       Date:  1987-08       Impact factor: 4.307

Review 6.  Albumin and its application in drug delivery.

Authors:  Darrell Sleep
Journal:  Expert Opin Drug Deliv       Date:  2014-12-18       Impact factor: 6.648

7.  Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysis.

Authors:  Sergei Zaitsev; Sergei Zaitzev; Dirk Spitzer; Juan-Carlos Murciano; Bi-Sen Ding; Samira Tliba; M Anna Kowalska; Khalil Bdeir; Alice Kuo; Victoria Stepanova; John P Atkinson; Mortimer Poncz; Douglas B Cines; Vladimir R Muzykantov
Journal:  J Pharmacol Exp Ther       Date:  2009-12-01       Impact factor: 4.030

Review 8.  Recent trends in targeted anticancer prodrug and conjugate design.

Authors:  Yashveer Singh; Matthew Palombo; Patrick J Sinko
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

9.  Molecular dynamics simulations of DiI-C18(3) in a DPPC lipid bilayer.

Authors:  Ramachandra R Gullapalli; Melik C Demirel; Peter J Butler
Journal:  Phys Chem Chem Phys       Date:  2008-05-07       Impact factor: 3.676

10.  Therapeutically engineered induced neural stem cells are tumour-homing and inhibit progression of glioblastoma.

Authors:  Juli R Bagó; Adolfo Alfonso-Pecchio; Onyi Okolie; Raluca Dumitru; Amanda Rinkenbaugh; Albert S Baldwin; C Ryan Miller; Scott T Magness; Shawn D Hingtgen
Journal:  Nat Commun       Date:  2016-02-02       Impact factor: 14.919

View more
  5 in total

Review 1.  Synthetic Receptor-Based Targeting Strategies to Improve Tumor Drug Delivery.

Authors:  Susheel Kumar Nethi; Shubhmita Bhatnagar; Swayam Prabha
Journal:  AAPS PharmSciTech       Date:  2021-03-08       Impact factor: 3.246

2.  Delivery of a model lipophilic membrane cargo to bone marrow via cell-derived microparticles.

Authors:  Chunyan Yang; Fangfang Chen; Ping Ren; Laren Lofchy; Chun Wan; Jingshi Shen; Guankui Wang; Hanmant Gaikwad; Jessica Ponder; Craig T Jordan; Robert Scheinman; Dmitri Simberg
Journal:  J Control Release       Date:  2020-07-16       Impact factor: 9.776

3.  Clickable Methyltetrazine-Indocarbocyanine Lipids: A Multicolor Tool Kit for Efficient Modifications of Cell Membranes.

Authors:  Hanmant Gaikwad; Guankui Wang; Weston J Smith; Keisha L Alexander; Angelo D'Alessandro; Wei Zhang; Enkhtsetseg Purev; Dmitri Simberg
Journal:  Bioconjug Chem       Date:  2019-05-03       Impact factor: 4.774

4.  Labeling of Erythrocytes by Porphyrin-Phospholipid.

Authors:  Sunanda Kumar; Dawei Jiang; Boyang Sun; Kaelyn V Seeley; Jonathan W Engle; Zachary Sia; Xuedan He; Sriram Neelamegham; Weibo Cai; Jonathan F Lovell
Journal:  Adv Nanobiomed Res       Date:  2020-10-16

5.  Liposomal Extravasation and Accumulation in Tumors as Studied by Fluorescence Microscopy and Imaging Depend on the Fluorescent Label.

Authors:  Guankui Wang; Markella Zannikou; Laren Lofchy; Yue Li; Hanmant Gaikwad; Irina V Balyasnikova; Dmitri Simberg
Journal:  ACS Nano       Date:  2021-07-01       Impact factor: 15.881

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.